Menu

Filter by category

22
May
2021

Why we need genomic and fertility law reform part V

Covid-19 is an effective mass disrupter with serious global morbidity and mortality implications. It is, however, just part of a wider complex picture that is rapidly evolving around us. With the continual development of powerful transformative gene-editing tools and scientific and digital technology we increasingly have the capacity to digitally programme, enhance and re-structure our genome and life itself. There is therefore an urgent need to implement intelligent genomic and fertility law reform and develop new policies and practices to deal with fallout from the Covid-19 global pandemic, changing geopolitics, evolving biopolitics, declining fertility levels and rapid intersection of genomics, digital, AI and assisted reproductive technology.
Read More
14
Dec
2020

Fertility, Genomics and Covid-19

Progress Educational Trust’s one-day annual conference entitled “Fertility, Genomics and Covid-19” took place on Wednesday 9 December 2020. For the first time, it took place virtually with a varied panel of expert international speakers. It generated thought-provoking and wide-ranging debate about the impact of the Covid-19 pandemic on our health and the fertility sector, including: the changing role of the HFEA, challenges for fertility treatment delivery, ethical issues, effect on individual fertility and the fetus and the genetic resilience of women.
Read More
20
Oct
2020

The UK’s New National Genomic Healthcare Strategy, Genome UK

On 19 October 2020 BioNews published a comment piece by specialist fertility and family lawyer Louisa Ghevaert which assesses the UK government's new National Genomic Healthcare Strategy, Genome UK. Louisa explains that this genomic healthcare strategy does not go far enough in repositioning future healthcare strategy, policy and practice. By not fully articulating and integrating human reproduction and fertility treatment into future genomic healthcare strategy, Louisa explains that it does not represent a truly cohesive approach in setting our genomic healthcare strategy 'over the next ten years' and beyond.
Read More
22
Sep
2020

Human Genome Editing: World Health Organization and Global Governance

Nearly two years has passed since news broke of the world’s first gene-edited babies in China in November 2018, triggering a global outcry about the risks of human genome editing and the creation of ‘designer babies’. This swiftly led to the establishment of an Expert Advisory Committee on Human Genome Editing in February 2019 by the Director-General of the World Health Organization (‘the WHO’). This Expert Committee is expected to publish its final recommendations for global governance and regulation of human genome editing technology later this year and in doing so there are big issues to tackle.
Read More

In the News

Father and toddler

X updates

Follow Louisa on X for latest industry updates

Read More

Articles & Publications

The latest news on fertility and modern family law

Read More

News & Commentary

Louisa discusses her opinion on different topics

Read More